OstéoQC Closes Seed Financing Round07-Nov-2014
OsteoQC Closes Seed Financing Round Montreal (Nov11, 2014) ..
OSTEOGENEX ANNOUNCES ISSUANCE OF A U.S. PATENT COVERING ANTI-SCLEROSTIN BISPHOSPHONATE COMBINATION T01-Jun-2012
OsteoGeneX, a Kansas City, Kansas-based pharmaceutical company, is focused on commercializing or..
OsteoGeneX, a Kansas City, Kansas-based pharmaceutical company, focused on commercializing orall..
Osteogenex Named One of Top 50 National Innovators At The 2012 Life Sciences & Health Ventur..
OsteoGeneX to Spin Off Commercialization Entity New Chief Commercial Officer to Drive Bone Thera..
OSTEOGENEX RAISES ADDITIONAL $1.4M IN CAPITAL AND ADDS MEMBER TO SCIENTIFIC ADVISORY BOARD ‐ COR..